Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03872414 · ClinicalTrials.gov registry record · NA
Emotion Study/Substudy: Flexible Brain Study
A NA study of Parkinson Disease and Aging, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
- 1
- Study location
NCT03872414: Completed NA study of Parkinson Disease and Aging, sponsored by University of Florida.
NCT03872414 is a NA study of Parkinson Disease and Aging that has completed, run by University of Florida. The registered enrollment target is 46 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03872414, a NA study of Parkinson Disease and Aging, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed research applies the highly innovative technology of real-time functional Magnetic Resonance Imaging (rtfMRI) to examine plasticity of brain-regulatory mechanisms related to cognitive and affective processing and to determine benefits for cognition and affect in young and older adults and in Parkinson Disease (PD) patients.
Primary Outcome
Change in blood-oxygen-level dependent (BOLD) signal response of the anterior cingulate cortex.
Conditions Studied
Interventions
- BEHAVIORAL Anterior cingulate cortex activation
- BEHAVIORAL Primary auditory cortex activation
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2023-05-08 |
| Phase | NA |
What the finished NCT03872414 record still lists
NCT03872414 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which Anterior cingulate cortex activation is the first listed.
NCT03872414 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03872414 about?
NCT03872414 is a clinical study titled "Emotion Study/Substudy: Flexible Brain Study". The proposed research applies the highly innovative technology of real-time functional Magnetic Resonance Imaging (rtfMRI) to examine plasticity of brain-regulatory mechanisms related to cognitive and affective processing and to determine benefits for cognition and affect in young and older adults a...
What is the current status of trial NCT03872414?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2019-04-01. Estimated completion is 2023-05-08.
What conditions does trial NCT03872414 study?
This clinical trial studies the following conditions: Parkinson Disease, Aging, Emotions.
What interventions are being tested in trial NCT03872414?
The interventions under investigation include: Anterior cingulate cortex activation (BEHAVIORAL), Primary auditory cortex activation (BEHAVIORAL).
Who is sponsoring clinical trial NCT03872414?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03872414 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03872414's enrollment target sits among peer trials
46 165th of 297 higher than 133 of 297 other Parkinson Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Neurophysiology of Reward Signaling in Parkinson's Disease
RECRUITING · NA
-
Balance Tele-Rehab in Parkinson's Disease Parkinson's Disease
RECRUITING · NA
-
Rock Steady Boxing: A Community Based In Person Class
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI